Pathophysiology and treatment of systemic amyloidosis

Systemic Amyloidosis in England: an epidemiological study

(2013) Jennifer H. Pinney et al.   BRITISH JOURNAL OF HAEMATOLOGY

Decreasing incidence of AA amyloidosis in Spain

(2013) Nayara Panizo et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Implantable Cardioverter Defibrillators in Patients with Cardiac Amyloidosis

(2013) GRACE LIN et al.   JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY

Cyclophosphamide, bortezomib, and dexamethasone therapy in AL amyloidosis is associated with high clonal response rates and prolonged progression-free survival

(2012) C. P. Venner et al.   BLOOD

Refinement in patient selection to reduce treatment-related mortality from autologous stem cell transplantation in amyloidosis

(2012) M A Gertz et al.   BONE MARROW TRANSPLANTATION

A prospective study of nutritional status in immunoglobulin light chain amyloidosis

(2012) P. T. Sattianayagam et al.   HAEMATOLOGICA

New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes

(2012) Giovanni Palladini et al.   JOURNAL OF CLINICAL ONCOLOGY

Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis

(2012) R L Comenzo et al.   LEUKEMIA

Tafamidis for transthyretin familial amyloid polyneuropathy: A randomized, controlled trial

(2012) T. Coelho et al.   NEUROLOGY

Hereditary Systemic Amyloidosis Due to Asp76Asn Variant β2-Microglobulin

(2012) Sophie Valleix et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antisense oligonucleotide suppression of serum amyloid A reduces amyloid deposition in mice with AA amyloidosis

(2011) Barbara Kluve-Beckerman et al.   AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS

Decline in the incidence of renal failure due to amyloidosis associated with inflammatory rheumatic diseases

(2011) K. Immonen et al.   AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS

Glycosaminoglycans promote fibril formation by amyloidogenic immunoglobulin light chains through a transient interaction

(2011) Douglas J. Martin et al.   BIOPHYSICAL CHEMISTRY

Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients

(2011) M. T. Cibeira et al.   BLOOD

Outcome in Renal AL Amyloidosis After Chemotherapy

(2011) Jennifer H. Pinney et al.   JOURNAL OF CLINICAL ONCOLOGY

Amyloidosis: Pathogenesis and New Therapeutic Options

(2011) Giampaolo Merlini et al.   JOURNAL OF CLINICAL ONCOLOGY

Hereditary lysozyme amyloidosis - phenotypic heterogeneity and the role of solid organ transplantation

(2011) P. T. Sattianayagam et al.   JOURNAL OF INTERNAL MEDICINE

Medullary amyloidosis associated with apolipoprotein A-IV deposition

(2011) Sanjeev Sethi et al.   KIDNEY INTERNATIONAL

Heparan sulfate/heparin promotes transthyretin fibrillization through selective binding to a basic motif in the protein

(2011) F. Noborn et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Leukocyte Chemotactic Factor 2 (LECT2)-Associated Renal Amyloidosis: A Case Series

(2010) Charles L. Murphy et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Solid Organ Transplantation in AL Amyloidosis

(2010) P. T. Sattianayagam et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Amyloid fibril protein nomenclature: 2010 recommendations from the nomenclature committee of the International Society of Amyloidosis

(2010) Jean D. Sipe et al.   AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS

Sustained pharmacological depletion of serum amyloid P component in patients with systemic amyloidosis

(2010) Julian D. Gillmore et al.   BRITISH JOURNAL OF HAEMATOLOGY

A primed state exists in vivo following histological regression of amyloidosis

(2010) P. N. HAWKINS et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

The Incidence of Major Hemorrhagic Complications After Renal Biopsies in Patients with Monoclonal Gammopathies

(2010) R. Fish et al.   Clinical Journal of the American Society of Nephrology

Usefulness and limitations of 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy

(2010) Claudio Rapezzi et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Inhibition of pathologic immunoglobulin-free light chain production by small interfering RNA molecules

(2010) Jonathan E. Phipps et al.   EXPERIMENTAL HEMATOLOGY

Role of Glycosaminoglycan Sulfation in the Formation of Immunoglobulin Light Chain Amyloid Oligomers and Fibrils

(2010) Ruiyi Ren et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Prevalence and morphology of leukocyte chemotactic factor 2-associated amyloid in renal biopsies

(2010) Christopher P. Larsen et al.   KIDNEY INTERNATIONAL

Antibodies to human serum amyloid P component eliminate visceral amyloid deposits

(2010) Karl Bodin et al.   NATURE

Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38  MAPK pathway

(2010) J. Shi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Biology of Amyloid: Structure, Function, and Regulation

(2010) Jason Greenwald et al.   STRUCTURE

Cardiac Transplantation Followed by Dose-Intensive Melphalan and Autologous Stem-Cell Transplantation for Light Chain Amyloidosis and Heart Failure

(2010) Bimalangshu R. Dey et al.   TRANSPLANTATION

Susceptibility to AA amyloidosis in rheumatic diseases: A critical overview

(2009) Laura Obici et al.   ARTHRITIS AND RHEUMATISM

Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens

(2009) J. A. Vrana et al.   BLOOD

Heparan sulfate promotes the aggregation of HDL-associated serum amyloid A: evidence for a proamyloidogenic histidine molecular switch

(2009) Elena Elimova et al.   FASEB JOURNAL

Kinetic Analysis of Amyloid Formation in the Presence of Heparan Sulfate

(2009) Neda Motamedi-Shad et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Quantitative assessment of myocardial T2 relaxation times in cardiac amyloidosis

(2009) Patrick Sparrow et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Clinical outcome of immunoglobulin light chain amyloidosis affecting the kidney

(2009) M. A. Gertz et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Beta2-Microglobulin

(2009) Tilman B. Drüeke et al.   SEMINARS IN DIALYSIS

Pathogenesis of and Therapeutic Strategies to Ameliorate the Transthyretin Amyloidoses

(2008) Yoshiki Sekijima et al.   CURRENT PHARMACEUTICAL DESIGN

Diagnosis, Pathogenesis, Treatment, and Prognosis of Hereditary Fibrinogen A -Chain Amyloidosis

(2008) J. D. Gillmore et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Leukocyte chemotactic factor 2: A novel renal amyloid protein

(2008) Merrill D. Benson et al.   KIDNEY INTERNATIONAL

Amyloidogenic and Associated Proteins in Systemic Amyloidosis Proteome of Adipose Tissue

(2008) Francesca Lavatelli et al.   MOLECULAR & CELLULAR PROTEOMICS

Prophylactic implantation of cardioverter-defibrillator in patients with severe cardiac amyloidosis and high risk for sudden cardiac death

(2007) Arnt V. Kristen et al.   HEART RHYTHM